The Substance Abuse and Mental Health Services Administration (SAMHSA) has announced the adoption of the revised Confidentiality of Substance Use Disorder Patient Records regulation, 42 CFR Part 2. The new rule advances the integration of healthcare for individuals with substance use disorders while maintaining critical privacy and confidentiality protections.

“This reform will help make it easier for Americans to discuss substance use disorders with their doctors, seek treatment, and find the road to recovery,” said Health and Human Services Secretary Alex Azar. “President Trump has made the availability of treatment for Americans with substance use disorders, including opioid use disorder, a priority. Thanks to the valuable input of stakeholders, our final rule will make it easier for Americans to seek and receive treatment while lifting burdens on providers and maintaining important privacy protections.”

More details on the new rule: